ThomasDBatiukMD

PubMed

• 4 citations
  Glomerular endothelial vesicles in a renal allograft: An unusual pattern of immunoglobulin deposition in a patient with biclonal gammopathy of unknown significance
  Ellen Flatley, Gerald M. Segal, Thomas D. Batiuk, William M. Bennett, Donald C. Houghton, Megan L. Troxell> ;The American Journal of Surgical Pathology. 2015 Jun 1
• Enteric oxalate nephropathy in the renal allograft: an underrecognized complication of bariatric surgery.
  Troxell, M. L.,Houghton, D. C.,Hawkey, M.,Batiuk, T. D.,Bennett, W. M.> ;Am J Transplant. 2013 Feb
• 34 citations
  Kidney transplantation in the morbidly obese: complicated but still better than dialysis.
  William M. Bennett, Kevin M. McEvoy, Karen R. Henell, Sudha Pidikiti, Viken Douzdjian, Thomas Batiuk> ;Clinical Transplantation. 2011 May 1
• 18 citations
  Surveillance and Modification of Immunosuppression Minimizes BK Virus Nephropathy
  William M. Bennett, Leslie Meyer, Jennifer Ridenour, Thomas D. Batiuk> ;American Journal of Nephrology. 2010 Jan 1
• 7 citations
  Severe Prolonged Tacrolimus Overdose with Minimal Consequences
  Laura L. Hardwick, Thomas D. Batiuk> ;Pharmacotherapy. 2002 Aug 1
• 7 citations
  Studies of renal injury IV: The GLUT1 gene protects renal cells from cyclosporine A toxicity
  Jesus H. Dominguez, Manoocher Soleimani, Thomas Batiuk> ;Kidney International. 2002 Jul 1
• 43 citations
  Creatinine Reduction Ratio and 24-Hour Creatinine Excretion on Posttransplant Day Two: Simple and Objective Tools to Define Graft Function
  Mahendra V. Govani, Osun Kwon, Thomas D. Batiuk, Martin L. Milgrom, Ronald S. Filo> ;Journal of the American Society of Nephrology. 2002 Jun 1
• 34 citations
  Infectious disease prophylaxis in renal transplant patients: a survey of US transplant centers
  Thomas D. Batiuk, Kenneth A. Bodziak, Mitch Goldman> ;Clinical Transplantation. 2002 Feb 1
• 24 citations
  Guanine nucleosides and Jurkat cell death: roles of ATP depletion and accumulation of deoxyribonucleotides
  Thomas D. Batiuk, Carol T. Schnizlein-Bick, Zoya Plotkin, Pierre C. Dagher> ;American Journal of Physiology. Cell Physiology. 2001 Dec 1
• 62 citations
  Tissue Distribution of Calcineurin and its Sensitivity to Inhibition by Cyclosporine
  Lina Kung, Thomas D. Batiuk, Silvia Palomo-Pinon, J. Noujaim, Lisa M. H. Helms, Philip F. Halloran> ;American Journal of Transplantation. 2001 Nov 1
• 38 citations
  A placebo-controlled trial to evaluate immunomodulatory effects of paricalcitol
  Sharon M. Moe, Mindaugas Zekonis, Jaroslaw Harezlak, Walter T. Ambrosius, Christine M. Gassensmith, Cynthia L. Murphy, Regina R. Russell, Thomas D. Batiuk> ;American Journal of Kidney Diseases. 2001 Oct 1
• 5 citations
  Broken kidney: traumatic fracture of a renal allograft.
  Sadiq Ahmed, Thomas D. Batiuk> ;American Journal of Kidney Diseases. 2001 Apr 1
• 12 citations
  Reduced intrapatient variability of cyclosporine pharmacokinetics in renal transplant recipients switched from oral sandimmune to neoral
  Robert Mendez, Hanna E. Abboud, James F. Burdick, Brian Copley, Richard B. Freeman, Thomas D. Batiuk, G F Cooney, Ralph Barbeito> ;Clinical Therapeutics. 1999 Jan 1
• 22 citations
  Calcineurin activity in children with renal transplants receiving cyclosporine
  Ramcel M. Quien, Bruce A. Kaiser, Stephen P. Dunn, Anatoly Kulinsky, Martin S. Polinsky, H J Baluarte, Thomas D. Batiuk, Philip F. Halloran> ;Transplantation. 1997 Nov 27
• 67 citations
  Evidence that calcineurin is rate-limiting for primary human lymphocyte activation.
  Thomas D. Batiuk, Lina Kung, Philip F. Halloran> ;The Journal of Clinical Investigation. 1997 Oct 1
• 20 citations
  The downstream consequences of calcineurin inhibition.
  Thomas D. Batiuk, Philip F. Halloran> ;Transplantation Proceedings. 1997 Feb 1
• 40 citations
  Quantitating immunosuppression. Estimating the 50% inhibitory concentration for in vivo cyclosporine in mice.
  Thomas D. Batiuk, Joan Urmson, Dianne Vincent, Randall W. Yatscoff, Philip F. Halloran> ;Transplantation. 1996 Jun 15
• 14 citations
  The functional consequences of partial calcineurin inhibition in human peripheral blood mononuclear leucocytes
  F. Pazderka, Janet Enns, Thomas D. Batiuk, Philip F. Halloran> ;Transplant Immunology. 1996 Mar 1
• 39 citations
  Cyclosporine inhibition of leukocyte calcineurin is much less in whole blood than in culture medium.
  Thomas D. Batiuk, F. Pazderka, J. Enns, L. De Castro, Philip F. Halloran> ;Transplantation. 1996 Jan 15
• 74 citations
  Cyclosporine inhibition of calcineurin activity in human leukocytes in vivo is rapidly reversible.
  Thomas D. Batiuk, F. Pazderka, J. Enns, L DeCastro, Philip F. Halloran> ;The Journal of Clinical Investigation. 1995 Sep 1
• 90 citations
  Calcineurin activity is only partially inhibited in leukocytes of cyclosporine-treated patients.
  Thomas D. Batiuk, F. Pazderka, Philip F. Halloran> ;Transplantation. 1995 May 1
• 8 citations
  Cyclosporine-treated renal transplant patients have only partial inhibition of calcineurin phosphatase activity.
  Thomas D. Batiuk, F. Pazderka, Philip F. Halloran> ;Transplantation Proceedings. 1995 Feb 1
• 6 citations
  What is the dose-response curve for the effects of cyclosporine on calcineurin and cytokine induction in vivo?
  Thomas D. Batiuk, Randall W. Yatscoff, Philip F. Halloran> ;Transplantation Proceedings. 1994 Oct 1
• 4 citations
  How do cells recover from inhibition by cyclosporine
  Thomas D. Batiuk, F. Pazderka, Philip F. Halloran> ;Transplantation Proceedings. 1994 Oct 1
• 10 citations
  A prospective, double-blind, randomized study of high-versus low-dose OKT3 induction immunosuppression in cadaveric renal transplantation.
  Douglas J. Norman, J A Kimball, William M. Bennett, Fuad S. Shihab, Thomas D. Batiuk, Mary M. Meyer, John M. Barry> ;Transplant International. 1994 Aug 1
• Join now to see all